Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.100
+0.010 (0.32%)
Jan 17, 2025, 4:00 PM EST - Market closed
Aquestive Therapeutics Employees
Aquestive Therapeutics had 135 employees as of December 31, 2023. The number of employees increased by 5 or 3.85% compared to the previous year.
Employees
135
Change (1Y)
5
Growth (1Y)
3.85%
Revenue / Employee
$436,296
Profits / Employee
-$260,689
Market Cap
282.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AQST News
- 14 days ago - Aquestive Therapeutics: Five Foci For 2025 - Seeking Alpha
- 2 months ago - Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics + - Seeking Alpha
- 2 months ago - Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aquestive: Rare Opportunity With Dual Platform Strategy - Seeking Alpha
- 2 months ago - Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th - GlobeNewsWire
- 5 months ago - Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings - Seeking Alpha